Skip to main content
SpringerLink
Log in

Patients’ attitudes towards and experiences of generic drug substitution in Norway

  • Research Article
  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

Abstract

Objective

The aim of the study was to assess patients’ attitudes towards and experiences of generic substitution 3 years after generic substitution of prescription medicines was permitted in Norway.

Methods

Prescriptions from 2,128 consecutive patients in a Norwegian pharmacy were retrospectively reviewed to identify all patients (n = 274) receiving eight or more different prescription drugs on the fifth level in the Anatomical Therapeutic Chemical (ATC) classification system during the last 6 months. An age-adjusted control group (n = 269) of patients receiving three to seven different prescription drugs was randomly selected. Of the 543 patients, 386 were eligible for inclusion. Both groups received a mailed questionnaire addressing their experiences with and attitudes towards generic substitution.

Results

The overall response rate was 73% (281/386) and the average age of the respondents was 66 years old. The study found that patients who reported to have received information from their physician or the pharmacy about generic substitution were more likely to have switched (P < 0.001). About half (138/281) of the patients had experienced a generic switch, and a higher proportion of the polypharmacy patients had their medication substituted compared to the control patients (P < 0.001). Altogether 50 (36%) of the patients who had experienced a switch, reported one or more negative experiences connected to the substitution, and 29 of these (21%) reported an overall negative experience after the change. The experiences of the patients were not related to age, gender, or number of medications or information about generics from either the pharmacy or the physician. About 41% of the patients would not switch if they had no personal economic incentives.

Conclusions

About 1/3 of the patients who had their medication substituted reported negative experiences. Generic drug substitution for a number of patients is not considered an equal alternative to branded drugs, and these patients may need additional information and support. The lack of correlation between patient experiences and age, gender, and medical regimen complexity is interesting and should be investigated further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aarseth HP. Why generic substitution? (In Norwegian). Tidskr Nor Laegefor 2001; 121(28):3339.

    Google Scholar 

  2. Husom N. Generic substitution - not at any price (In Norwegian). Tidskr Nor Laegefor 2004; 124(16):2165.

    Google Scholar 

  3. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 25(11):2875–90.

    Article  PubMed  Google Scholar 

  4. Tilyard MW, Dovey SM, Rosenstreich D. General practitioners’ views on generic medication and substitution. N Z Med J 1990; 103(893):318–20.

    PubMed  CAS  Google Scholar 

  5. Colaizzi JL, Lowenthal DT. Critical therapeutic categories: a contraindication to generic substitution? Clin Ther 1986; 8(4):370–9.

    PubMed  CAS  Google Scholar 

  6. Reiffel JA. Issues in the use of generic antiarrhythmic drugs. Curr Opin Cardiol 2001; 16(1):23–29.

    Article  PubMed  CAS  Google Scholar 

  7. Welty TE, Pickering PR, Hale BC, Arazi R. Loss of seizure control associated with generic substitution of carbamazepine. Ann Pharmacother 1992; 26(6):775–7.

    PubMed  CAS  Google Scholar 

  8. Williamson IJ, Reid A, Monie RD, Fennerty AG, Rimmer EM. Generic inhaled salbutamol versus branded salbutamol. A randomised double-blind study. Postgrad Med J 1997; 73(857):156–8.

    Article  PubMed  CAS  Google Scholar 

  9. Murphy JE. Generic substitution and optimal patient care. Arch Intern Med 1999; 159(5):429–33.

    Article  PubMed  CAS  Google Scholar 

  10. Banahan BF, III, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med 1997; 157(18):2080–88.

    Article  PubMed  Google Scholar 

  11. Nordling S, Lindberg G, Sandberg S, Anell A, Melander A, Rydberg T. Hur gikk det med försöket med generisk substitusjon i Skåne? En rapport från IHE, NEPI og Apoteken i Skåne. (In Swedish) 2000. Kristianstad, Apotekarsocieteten. ISBN 91-8627-489-9.

  12. Madsen S, Huse J, Roksvaag PO. [Pharmacy customers’ attitude to generics] In Norwegian. Tidsskr Nor Laegeforen 2003; 123(6):792–3.

    PubMed  Google Scholar 

  13. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc 2000; 40(3):378–83.

    CAS  Google Scholar 

  14. Mott DA, Cline RR. Exploring generic drug use behaviour: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002; 40(8):662–74.

    Article  PubMed  Google Scholar 

  15. Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci 1999; 21(6):260–5.

    Article  PubMed  CAS  Google Scholar 

  16. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997–2000. Ann Intern Med 2005; 142(11):891–7.

    PubMed  Google Scholar 

  17. Lund-Jacobsen B. [Generic substitution – patients’ incentives are too low]. Ugeskr Laeger 1992; 154(46):3215–6.

    PubMed  CAS  Google Scholar 

  18. Andersson K, Sonesson C, Petzold M, Carlsten A, Lonnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf 2005; 14(5):341–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Pharmacy Practice Research, Kalfarveien 31, N-5018, Bergen, Norway

    Inge Kjoenniksen & Anne Gerd Granas

  2. Department of General Practice and Community Medicine, University of Oslo, 0317, Oslo, Norway

    Morten Lindbaek

Authors
  1. Inge Kjoenniksen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morten Lindbaek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne Gerd Granas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne Gerd Granas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kjoenniksen, I., Lindbaek, M. & Granas, A.G. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 28, 284–289 (2006). https://doi.org/10.1007/s11096-006-9043-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-006-9043-5

Keywords

Search

Navigation